A vaccine that’s widely known to help protect women from cervical cancer can also offer significant health benefits ... HPV vaccination was linked with lower rates of HPV-related cancers in men ...

HPV vaccination has long been linked to reduced cervical cancers in women. New research shows that the HPV vaccine dramatically reduces the risk of head and neck cancers, especially in boys and men.

Human papillomavirus (HPV) is the virus that causes cervical cancer in women and genital warts in men and women ... the American Cancer Society. The HPV vaccine prevents infection by the HPV ...

particularly among men from 40 to 60 years of age. The CDC recommends children receive two doses of HPV vaccine starting at ages 11 to 12, although the two inoculations can begin as early as nine ...

This trial supports the continued expansion of HPV vaccine use — and provides an additional reason to immunize boys before the onset of sexual activity.

HPV vaccination historically has been framed as a women’s health topic, but a gender-neutral approach to prevention may boost health benefits for everyone.

The HPV vaccine’s safety has remained excellent, and the benefits are proven. It lowers your risk of getting ... That’s one reason we’re seeing more and more head and neck cancers in men in their 50s ...

There are several benefits to getting the HPV vaccine as an adult, especially for people who weren’t vaccinated during adolescence: Although the vaccine is most effective before exposure to the ...

This means both men and women are at risk for HPV-related cancers ... shows the impact the HPV vaccine is having on cervical cancer, Eckert stresses that the benefits could extend to more deadly ...

Each year, HPV causes approximately 36,000 cases of cancer in men ... vaccine — compared to other immunizations — may not fall as high on the list of priority protections, despite its benefits.

becoming the first and only HPV vaccine authorized for use in men in China, according to the vaccine's company Merck Sharp & Dohme on Wednesday. The quadrivalent HPV vaccine (Saccharomyces ...